Cart
sales@molnova.com
CX08005
CAS No. 1256341-22-6
CX08005( —— )
Catalog No. M34923 CAS No. 1256341-22-6
CX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 216 | In Stock |
|
| 10MG | 334 | In Stock |
|
| 25MG | 630 | In Stock |
|
| 50MG | 871 | In Stock |
|
| 100MG | 1172 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2344 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCX08005
-
NoteResearch use only, not for human use.
-
Brief DescriptionCX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
-
DescriptionCX08005 is a competitive PTP1B inhibitor. CX08005 can directly enhance the action of insulin in vivo and in vitro and improve insulin resistance.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256341-22-6
-
Formula Weight453.61
-
Molecular FormulaC28H39NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C1=C(C(O)=O)C=CC=C1)C2=C(OCCCCCCCCCCCCCC)C=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang X, et al. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance. Br J Pharmacol. 2016 Jun;173(12):1939-49.?
molnova catalog
related products
-
AS1949490
AS1949490 activated glucose metabolism via up-regulation of GLUT1 gene in L6 myotubes.
-
LMPTP INHIBITOR 1 hy...
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
Ertiprotafib
Ertiprotafib (PTP 112), a selective and potent inhibitor of protein tyrosine phosphate 1B (PTP1B) and IkappaB kinase β (IKK-β), is a novel insulin sensitizer with potential anticancer activity for the study of type 2 diabetes and breast cancer.
